Ugrás a tartalomra
Merck
Összes fotó(1)

Fontos dokumentumok

View All Documentation

T2500100

Trimyristin

European Pharmacopoeia (EP) Reference Standard

Szinonimák:

Glyceryl trimyristate, 1,2,3-Tritetradecanoylglycerol, Glycerol trimyristate, Trimyristin

Bejelentkezésa Szervezeti és Szerződéses árazás megtekintéséhez
Összes fotó(1)

About This Item

Lineáris képlet:
[CH3(CH2)12COOCH2]2CHOCO(CH2)12CH3
CAS-szám:
555-45-3
Molekulatömeg:
723.16
Beilstein:
1718242
MDL-szám:
MFCD00036229
UNSPSC kód:
41116107
PubChem Substance ID:
329826710
NACRES:
NA.24

grade

pharmaceutical primary standard

API-család

trimyristin

gyártó/kereskedő neve

EDQM

mp

56-57 °C (lit.)

alkalmazás(ok)

pharmaceutical (small molecule)

format

neat

tárolási hőmérséklet

−20°C

SMILES string

CCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC

InChI

1S/C45H86O6/c1-4-7-10-13-16-19-22-25-28-31-34-37-43(46)49-40-42(51-45(48)39-36-33-30-27-24-21-18-15-12-9-6-3)41-50-44(47)38-35-32-29-26-23-20-17-14-11-8-5-2/h42H,4-41H2,1-3H3

Nemzetközi kémiai azonosító kulcs

DUXYWXYOBMKGIN-UHFFFAOYSA-N

Looking for similar products? Látogasson el ide Útmutató a termékösszehasonlításhoz

Related Categories

Általános leírás

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Alkalmazás

Trimyristin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Kiszerelés

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Egyéb megjegyzések

Sales restrictions may apply.

Tárolási osztály kódja

11 - Combustible Solids

WGK

WGK 1

Lobbanási pont (F)

Not applicable

Lobbanási pont (C)

Not applicable

Válasszon a legfrissebb verziók közül:

Analitikai tanúsítványok (COA)

Lot/Batch Number

Sajnos jelenleg COA nem áll rendelkezésre ehhez a termékhez online.

Ha segítségre van szüksége, lépjen velünk kapcsolatba Vevőszolgálat

Már rendelkezik ezzel a termékkel?

Az Ön által nemrégiben megvásárolt termékekre vonatkozó dokumentumokat a Dokumentumtárban találja.

Dokumentumtár megtekintése

Az ügyfelek ezeket is megtekintették

Slide 1 of 1

1 of 1

Tricaprylin European Pharmacopoeia (EP) Reference Standard

T1978000

Tricaprylin

Kunal Jain et al.
Drug delivery, 22(7), 940-954 (2014-02-12)
The objective of the study was to optimize artemether-loaded nanostructured lipid carriers (ARM-NLC) for intranasal delivery using central composite design. ARM-NLC was prepared by microemulsion method with optimized formulation having particle size of 123.4 nm and zeta potential of -34.4
Krishnan Ganesh Prasath et al.
Journal of proteomics, 208, 103503-103503 (2019-08-28)
Candida albicans, a dimorphic opportunistic fungus is known to form robust biofilm and commonly associated with superficial and life threatening systemic infections. The repertoire of C. albicans infection is comprehensive due to its biofilm mediated virulence and occurrence of resistance
Sabrina Knoke et al.
Pharmaceutics, 13(2) (2021-02-03)
Knowledge about the release behavior and drug retention properties of colloidal carriers is of essential importance for quality control as well as to predict in vivo performance. When conducting release studies from such systems, the release media should preferentially contain
Yi-Ping Fang et al.
International journal of nanomedicine, 7, 4995-5005 (2012-10-12)
The synthetic potential chemotherapeutic agent 3-Chloro-4-[(4-methoxyphenyl) amino]furo[2,3-b]quinoline (PK-L4) is an analog of amsacrine. The half-life of PK-L4 is longer than that of amsacrine; however, PK-L4 is difficult to dissolve in aqueous media, which is problematic for administration by intravenous injection.
Mukta Agrawal et al.
Journal of controlled release : official journal of the Controlled Release Society, 321, 372-415 (2020-02-18)
In last two decades, the lipid nanocarriers have been extensively investigated for their drug targeting efficiency towards the critical areas of the human body like CNS, cardiac region, tumor cells, etc. Owing to the flexibility and biocompatibility, the lipid-based nanocarriers
View All Related Papers

Tudóscsoportunk valamennyi kutatási területen rendelkezik tapasztalattal, beleértve az élettudományt, az anyagtudományt, a kémiai szintézist, a kromatográfiát, az analitikát és még sok más területet.

Lépjen kapcsolatba a szaktanácsadással